` INDP (Indaptus Therapeutics Inc) vs S&P 500 Comparison - Alpha Spread

INDP
vs
S&P 500

Over the past 12 months, INDP has underperformed S&P 500, delivering a return of -92% compared to the S&P 500's +16% growth.

Stocks Performance
INDP vs S&P 500

Loading
INDP
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
INDP vs S&P 500

Performance Gap Between INDP and GSPC
HIDDEN
Show

Performance By Year
INDP vs S&P 500

Loading
INDP
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Indaptus Therapeutics Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Indaptus Therapeutics Inc
Glance View

Market Cap
3.8m USD
Industry
Biotechnology

Indaptus Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm is focused on enhancing and expanding curative cancer immunotherapy for patients with unresectable or metastatic solid tumors and lymphomas. The company designs its approach by targeting specific tumor or viral antigens. Its lead candidate, Decoy20, is in pre-clinical development. Its platform is based on the hypothesis that require anti-tumor immunotherapy to activate both innate and adaptive cellular immunity in both tumors and immune organs. Its approach uses multi-targeted package of bacterial pathogen-associated molecular patterns (PAMPs) in the form of attenuated and killed, intact but non-pathogenic bacteria delivered intravenously. Its intravenous therapeutic candidates target the liver, spleen, and leaky vasculature of tumors, producing immune activation in an immune organ, as well as a common site for primary and metastatic cancer and hepatitis B virus (HBV) infection.

INDP Intrinsic Value
Not Available
Back to Top